Business Description
Arcede Pharma AB
ISIN : SE0018168742
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.85 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | -2.09 | |||||
Beneish M-Score | -10.43 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Book Growth Rate | 463.6 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 33.49 | |||||
9-Day RSI | 39.65 | |||||
14-Day RSI | 43.38 | |||||
6-1 Month Momentum % | -8.49 | |||||
12-1 Month Momentum % | -55.2 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.17 | |||||
Quick Ratio | 1.17 | |||||
Cash Ratio | 1.01 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -29.8 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -55008.77 | |||||
Net Margin % | -55007.02 | |||||
FCF Margin % | -11695.77 | |||||
ROE % | -84.54 | |||||
ROA % | -76.69 | |||||
ROIC % | -77.9 | |||||
ROC (Joel Greenblatt) % | -328.22 | |||||
ROCE % | -84.53 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 3.78 | |||||
PB Ratio | 0.51 | |||||
Price-to-Tangible-Book | 8.94 | |||||
Price-to-Free-Cash-Flow | 1.12 | |||||
Price-to-Operating-Cash-Flow | 1.12 | |||||
EV-to-EBIT | -0.48 | |||||
EV-to-EBITDA | -2.03 | |||||
EV-to-Revenue | 265 | |||||
EV-to-FCF | -1.89 | |||||
Price-to-Net-Current-Asset-Value | 8.94 | |||||
Earnings Yield (Greenblatt) % | -206.12 | |||||
FCF Yield % | -41.39 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Arcede Pharma AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | 0.071 | ||
EPS (TTM) (kr) | -0.369 | ||
Beta | 0 | ||
Volatility % | 266.34 | ||
14-Day RSI | 43.38 | ||
14-Day ATR (kr) | 0.012176 | ||
20-Day SMA (kr) | 0.09941 | ||
12-1 Month Momentum % | -55.2 | ||
52-Week Range (kr) | 0.05 - 1.45 | ||
Shares Outstanding (Mil) | 168.96 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Arcede Pharma AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Arcede Pharma AB Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
Arcede Pharma AB Frequently Asked Questions
What is Arcede Pharma AB(XSAT:ARCEDE)'s stock price today?
When is next earnings date of Arcede Pharma AB(XSAT:ARCEDE)?
Does Arcede Pharma AB(XSAT:ARCEDE) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |